Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Vaccines01:30

Cancer Vaccines

936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Endocrine oncology (Bristol, England)·2026
Same author

External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial.

The Journal of urology·2026
Same author

Micro-ultrasound for prostate cancer.

Nature reviews. Urology·2025
Same author

Imaging in focal therapy: advanced ultrasound imaging and mpMRI-a comprehensive review.

Prostate cancer and prostatic diseases·2025
Same author

Metformin Active Surveillance Trial in Low-Risk Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

External Validation of the International Staging Collaboration for Cancer of the Prostate (STAR-CAP) Prognostic System in Patients Managed with Active Surveillance.

European urology open science·2025
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
查看所有相关文章

相关实验视频

Updated: Jan 10, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

647

积极监测前列腺癌的情况.

Laurence Klotz1

  • 1Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, #MG 408, Toronto, Ontario M4N3M5, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

The Urologic clinics of North America
|November 20, 2025
PubMed
概括
此摘要是机器生成的。

积极监测 (AS) 是有利风险前列腺癌的首选管理策略. 它已经从PSA监测和活检演变为结合新的工具和更好地了解前列腺癌生物学.

关键词:
积极监视活动的监视活动.保守的管理方式.低风险 低风险 低风险前列腺癌是什么意思 前列腺癌是什么意思

更多相关视频

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

1.2K

相关实验视频

Last Updated: Jan 10, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

647
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

1.2K

科学领域:

  • 在瘤学瘤学.
  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科

背景情况:

  • 积极监测 (AS) 是对前列腺癌风险有利的管理策略,成立于20多年前.
  • 最初,AS涉及PSA监测和定期活检,通过PSA增加或癌症升级引发干预.

研究的目的:

  • 描述前列腺癌主动监测协议的演变和改进.
  • 突出新型工具的影响和更好地了解前列腺癌生物学对AS的影响.

主要方法:

  • 对前列腺癌的历史AS协议的审查.
  • 纳入诊断工具的进步和对前列腺癌生物学的理解.

主要成果:

  • 积极监测现在是治疗前列腺癌风险较高的治疗标准.
  • 通过技术和生物见解,AS路径已经得到了显著的改进.

结论:

  • 积极监控协议已经取得了相当大的进步.
  • 精细的AS策略为有利风险的前列腺癌患者提供了改进的管理.